I have nearly succeeded in suicide 4 times. So despite the fact that I work has never made me less likely to do so.
I have participated in a number of trials - all with risks, some of them possibly severe - it is up to the individual to assess those risks.
Horners syndrome - the dropping eyelid, shortness of breath are a known side-effect of both SGB and Interscalene nerve blocks. And yes it is usually temporary. But if the stellate ganglion is damaged or the interscalene nerve is damaged, it will be permanent.
When I did pain management, I did SGBs. I still do interscalene nerve blocks almost daily as I work in a busy hospital where we do ortho 5 days a week. I have an honest discussion with patients about the risks. In the last 5 years I have done more than 1000 blocks. I have had one patient who got rapid lymphatic uptake - an event that occurs about 1:2000 blocks.
Recalling the German data, if everyone on this website gets a stellate ganglion block, then about 34 can expect to have a bad outcome - a complication that is serious.
Dr. Lipov had an abstract that included 7 patients which not not blinded in any way :
Pain Physician 2011; 14:E465-E491 • ISSN 2150-1149. His book is based on the work that he has done, and yest the block is being investigated in several different platforms by others - that is the way successful research is done.
The risks of any drug or procedure are borne by the patient, not the physician or drug company.
If a treatment fails for you - that can also make you suicidal. 2 years ago after emergency knee surgery I was unable to run because of a foot drop from the surgery itself - over the course of the next several months I became quite suicidal and had to stop working and get very intensive therapy.
The drug trial I will participate in beginning in February has the risk of liver failure - but I will have blood tests every 14 days and medication will be stopped if my liver begins to fail. But the science behind the drug is well concieved and based on previous randomized controlled trials. So I am willing to take the risk. But I wouldn't recommend the trial for every PTSD patient.
I have participated in a number of trials - all with risks, some of them possibly severe - it is up to the individual to assess those risks.
Horners syndrome - the dropping eyelid, shortness of breath are a known side-effect of both SGB and Interscalene nerve blocks. And yes it is usually temporary. But if the stellate ganglion is damaged or the interscalene nerve is damaged, it will be permanent.
When I did pain management, I did SGBs. I still do interscalene nerve blocks almost daily as I work in a busy hospital where we do ortho 5 days a week. I have an honest discussion with patients about the risks. In the last 5 years I have done more than 1000 blocks. I have had one patient who got rapid lymphatic uptake - an event that occurs about 1:2000 blocks.
Recalling the German data, if everyone on this website gets a stellate ganglion block, then about 34 can expect to have a bad outcome - a complication that is serious.
Dr. Lipov had an abstract that included 7 patients which not not blinded in any way :
Pain Physician 2011; 14:E465-E491 • ISSN 2150-1149. His book is based on the work that he has done, and yest the block is being investigated in several different platforms by others - that is the way successful research is done.
The risks of any drug or procedure are borne by the patient, not the physician or drug company.
If a treatment fails for you - that can also make you suicidal. 2 years ago after emergency knee surgery I was unable to run because of a foot drop from the surgery itself - over the course of the next several months I became quite suicidal and had to stop working and get very intensive therapy.
The drug trial I will participate in beginning in February has the risk of liver failure - but I will have blood tests every 14 days and medication will be stopped if my liver begins to fail. But the science behind the drug is well concieved and based on previous randomized controlled trials. So I am willing to take the risk. But I wouldn't recommend the trial for every PTSD patient.